Citius Pharmaceuticals, Inc.
CTXRNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $9.70M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.41$1.98
- Volume (live)
- -
- Avg. volume (3M)
- 207.00K
Citius Pharmaceuticals (CTXR) Stock Price & Financial Analysis
Citius Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.37 - $0.39 |
|---|---|
| 52-Week High | $1.98 |
| 52-Week Low | $0.41 |
| Open | $0.39 |
| Volume (last close) | 341.37K |
| Average Volume (3M) | 207.00K |
| Revenue (TTM) | 7.11M |
|---|---|
| Net Income (TTM) | -46.27M |
| Free Cash Flow (TTM) | -37.47M |
| EPS (TTM) | −$2.12 |
| Profit Margin | -651.27% |
| Operating Margin | -831.64% |
| Return on Equity (ROE) | -69.47% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 9.70M |
|---|---|
| Shares Outstanding | 26.17M |
| Price to Sales (P/S) | 1.37 |
| Price to Book (P/B) | 0.15 |
| EV/EBITDA | 0.01 |
| 50-Day MA | $0.57 |
|---|---|
| 200-Day MA | $0.67 |
| 1-Year Change | −78.44% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Citius Pharmaceuticals at a Glance
As of the Oct 22, 2026 close, Citius Pharmaceuticals (CTXR) has a market capitalization of $9.70M. The stock trades at 1.4× sales. Over the trailing twelve months it lost $46.27M on revenue of $7.11M and burned $37.47M of free cash flow. Revenue grew 4456.8% year over year.
As of its latest reported balance sheet, it holds $17.01M in cash and securities against $6.59M of debt, a net cash position of $10.42M.
Citius Pharmaceuticals does not currently pay a dividend.
The share price is down 78.4% over the past year. At $0.37 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.41 to $1.98, below its 200-day moving average of $0.67.
Frequently Asked Questions About Citius Pharmaceuticals
What is the current stock price for CTXR?
As of the Oct 22, 2026 close, CTXR stock trades at $0.37. The 52-week range is $0.41–$1.98, with a day range of $0.37–$0.39.
What is the P/E ratio for CTXR?
The P/E ratio (Price-to-Earnings) for CTXR is shown in the Key Statistics section. This valuation metric helps compare Citius Pharmaceuticals, Inc. to industry peers.
Does CTXR pay dividends?
Citius Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CTXR?
Analyst ratings and recommendations for CTXR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of CTXR?
As of the Oct 22, 2026 close, Citius Pharmaceuticals's market capitalization is $9.7M, classifying it as a micro-cap company. Citius Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.